May 10, 2021 -- A pancoronavirus vaccine candidate created by the Infectious Disease Research Institute (IDRI), the Duke Human Vaccine Institute, and 3M shows potential to protect against variants of SARS-CoV-2, according to a study published May 10 in Nature.
The vaccine candidate combines a Duke-developed nanoparticle with IDRI's formulation of 3M's 3M-052 compound. The study shows that it boosts production of neutralizing antibodies against several coronavirus strains.
The drug not only could protect against coronaviruses but also reduce the need for booster shots, according to Dr. Corey Casper, CEO of IDRI.